LJPC

La Jolla Pharmaceutical Co

-$16.6M

Net Activity

Institutions Holding

42

Popularity Rank

#6562

Avg Weight

2.71%

Total Value

$53.9M

Ownership Trend

42 institutions currently hold LJPC, with 2 net buyers and 8 net sellers this quarter.

Institutional Moves

Institutional Moves (Q2 2022)

Significantly Decreased

Based on recent trading activity

Net Selling Institutions

8

Net Buying Institutions

2

Key Holders

View all 42 holding institutions

Quarterly Activity

Recent Activity

+$127.0K

Total Buy Value

$5.7M

Total Sell Value

New buy0
Trim5
Add2
Sold out3

2

Net Buyers

8

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding LA JOLLA PHARMACEUTICAL CO (LJPC)?
Major stakeholders currently include Tang Capital Management LLC ($30.6M), Rtw Investments, LP ($7.4M), Atle Fund Management AB ($4.0M). Based on the latest 13F filings, there are a total of 42 tracked investment funds and institutions maintaining positions in LJPC.
What is the overall institutional sentiment toward LJPC recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $16.6M, driven by 2 managers accumulating shares while 8 reduced their exposure.
Which institutions have been selling or reducing their LJPC positions?
In the latest period, 5 funds trimmed their holdings, and 3 managers completely exited their positions. The aggregate reported sell value was $5.7M.
Are there any notable investors adding LJPC to their portfolios?
Yes, buying activity remains notable. 0 institutions opened new positions in {ticker}, and 2 existing holders added to their shares. The total reported buy value for the quarter amounted to $127.0K.

Related Stocks